Production (Stage)
iSpecimen Inc.
ISPC
$1.14
$0.021.79%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -13.05% | -6.42% | 0.74% | 3.82% | -14.45% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -13.05% | -6.42% | 0.74% | 3.82% | -14.45% |
| Cost of Revenue | 6.14% | 10.01% | 12.56% | 14.21% | -1.36% |
| Gross Profit | -32.56% | -21.92% | -9.56% | -4.82% | -24.63% |
| SG&A Expenses | -10.15% | 3.74% | -11.22% | -13.93% | -6.85% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -7.04% | 4.37% | -2.92% | -3.32% | -1.46% |
| Operating Income | 2.25% | -13.96% | 6.53% | 9.69% | -12.12% |
| Income Before Tax | 2.73% | -12.60% | 6.50% | 8.73% | -12.39% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 2.73% | -12.60% | 6.50% | 8.73% | -12.39% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 2.73% | -12.60% | 6.50% | 8.73% | -12.39% |
| EBIT | 2.25% | -13.96% | 6.53% | 9.69% | -12.12% |
| EBITDA | 2.86% | -13.35% | 7.95% | 10.92% | -10.87% |
| EPS Basic | 53.43% | 28.67% | 16.31% | 13.81% | -10.15% |
| Normalized Basic EPS | 53.43% | 28.68% | 16.31% | 13.81% | -10.16% |
| EPS Diluted | 53.43% | 28.67% | 16.42% | 13.91% | -10.01% |
| Normalized Diluted EPS | 53.43% | 28.68% | 16.31% | 13.81% | -10.16% |
| Average Basic Shares Outstanding | 159.36% | 57.21% | 20.28% | 7.85% | 2.02% |
| Average Diluted Shares Outstanding | 159.36% | 57.21% | 20.28% | 7.85% | 2.02% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |